+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Direct-to-Consumer Genetic Testing Market - Global Forecast 2026-2032- Product Image
Direct-to-Consumer Genetic Testing Market - Global Forecast 2026-2032- Product Image
Sale

Direct-to-Consumer Genetic Testing Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968843
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Direct-to-Consumer Genetic Testing Market is projected to reach USD 2.66 Billion in 2026. It is expected to continue growing at a CAGR of 14.37%, reaching USD 5.98 Billion by 2032.

Direct-to-consumer genetic testing is moving from novelty ancestry discovery toward a broader consumer health, wellness, pharmacogenomics, and preventive-care ecosystem. The category is supported by verified scientific progress: the National Human Genome Research Institute has documented a steep decline in DNA sequencing costs since the Human Genome Project, while public resources such as ClinVar, gnomAD, and the GWAS Catalog continue to improve variant interpretation and evidence transparency.

Consumer demand is strongest where digital health adoption, e-commerce access, and genetic literacy intersect. Industry growth remains tied to trust: CLIA-certified laboratory processes in the United States, GDPR-aligned consent in Europe, and transparent data-use policies are increasingly central to brand differentiation in direct-to-consumer DNA testing, genetic ancestry testing, health risk screening, carrier testing, pharmacogenomics, and nutrition genomics.

Transformative Shifts in the Genetic Testing Landscape

The landscape is being reshaped by the convergence of lower sequencing costs, high-throughput genotyping, secure digital platforms, and consumer preference for personalized health insights. DTC genetic testing providers are expanding beyond ancestry into polygenic risk scores, pharmacogenetic markers, inherited condition screening, wellness traits, and family-planning applications, supported by advances in bioinformatics and digital report delivery.

Regulation is also transforming market behavior. FDA oversight of health-related genetic tests, FTC scrutiny of privacy and advertising claims, HIPAA limitations for non-covered consumer platforms, GDPR requirements in Europe, and country-specific rules on genetic data export are pushing providers toward more rigorous validation, clearer disclosures, stronger consent management, and improved post-test support.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the full DTC genetic testing value chain, from sample quality control and genotype imputation to variant classification, report generation, risk communication, and customer support. Machine learning models can help prioritize variants, detect population-specific signals, and connect genetic results with phenotype, lifestyle, and electronic health record data where legally permitted and ethically governed.

The cumulative impact is not only operational efficiency but also higher expectations for explainability, auditability, and bias control. Because genomic databases remain unevenly representative across ancestries, AI-driven genetic testing reports must disclose evidence strength, validation cohorts, clinical limitations, and uncertainty thresholds to avoid overstated health claims and inequitable risk prediction.

Key Regional Insights

North America leads adoption through mature e-commerce channels, consumer health awareness, CLIA laboratory infrastructure, genetic counseling access, and FDA-authorized pathways for selected health-related genetic reports. Europe is shaped by GDPR, national bioethics frameworks, and the EU In Vitro Diagnostic Regulation, which favor evidence-based claims, explicit consent, privacy-by-design business models, and stricter clinical performance documentation for health-related genetic testing.

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and Singapore invest in genomics, precision medicine, and digital health infrastructure. Latin America is emerging through Brazil and Mexico, where private diagnostics networks, telehealth adoption, and urban consumer demand are growing. The Middle East, especially Gulf markets, is supported by national genome initiatives and high investment in preventive care, while Africa remains strategically important because global genomic datasets are still underrepresentative of African ancestry, creating both scientific need and long-term opportunity for more inclusive direct-to-consumer genetic testing.

Key Group Insights

The G7 remains central to commercialization because the United States, Canada, the United Kingdom, Germany, France, Italy, and Japan combine advanced laboratory systems, high purchasing power, established digital health usage, and active regulatory oversight. The European Union is especially influential through GDPR and IVDR, setting global expectations for consent, transparency, clinical evidence, post-market surveillance, and cross-border data governance in consumer genomics.

BRICS markets offer scale and genomic diversity, with China and India providing large populations and expanding genomics infrastructure, while Brazil, Russia, and South Africa contribute regional representation and underrepresented genomic data potential. ASEAN is gaining traction through Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, driven by digital health adoption, private healthcare expansion, and medical tourism. GCC markets are investing in national genome programs and preventive medicine, and NATO countries broadly align with data security, cyber resilience, trusted health technology, and protection of sensitive genetic information.

Key Country Insights

The United States remains the benchmark market for DTC genetic testing due to large consumer adoption, CLIA-certified laboratories, venture-backed digital health innovation, and FDA-authorized genetic health reports. Canada emphasizes privacy, consent, and responsible health communication, while Mexico and Brazil show rising demand through private diagnostics, telehealth, and urban middle-class health spending. The United Kingdom has strong genomic medicine infrastructure and public genomics expertise, while Germany, France, Italy, and Spain require careful alignment with national health, privacy, medical device, and laboratory rules.

China is scaling genomics through research capacity, sequencing infrastructure, and domestic digital health platforms, while India is gaining momentum through affordable diagnostics, preventive wellness demand, and expanding healthcare access. Japan and South Korea benefit from advanced healthcare systems, high technology adoption, and strong biomedical research capabilities. Australia supports consumer genetic testing through digital health engagement, research-grade genomics, and established laboratory standards, while Russia remains a complex market shaped by local data rules, scientific capacity, import constraints, and geopolitical considerations.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize analytical validity, clinical validity, and consumer comprehension across every product category. Health-related genetic reports should use clearly graded evidence, ancestry-aware risk models, transparent limitations, and access to clinicians or genetic counselors for results that may influence medical decisions, reproductive planning, medication selection, or preventive care.

Commercial teams should invest in privacy-first consent architecture, transparent data monetization policies, cybersecurity, lifecycle data governance, and localized regulatory strategies. Strategic partnerships with accredited laboratories, telehealth providers, healthcare systems, pharmaceutical researchers, and population genomics programs can improve scientific quality and operational scale while preserving trust in the direct-to-consumer genetic testing market.

Research Methodology

This executive summary is built from verified secondary research, regulatory analysis, and industry triangulation. Sources considered include public guidance and databases from the FDA, FTC, NIH, NHGRI, CDC, European Commission, national health authorities, peer-reviewed genomics literature, clinical variant repositories, laboratory quality standards, privacy regulations, and recognized data protection frameworks.

The methodology emphasizes data-backed interpretation rather than speculative claims. Market signals were evaluated across technology adoption, regulatory frameworks, laboratory infrastructure, consumer behavior, AI readiness, privacy requirements, genetic counseling access, public genomics initiatives, and regional genomics investment to identify sustainable growth drivers and risk factors.

Conclusion

Direct-to-consumer genetic testing is entering a more regulated, clinically connected, and AI-enabled phase. Growth potential will be strongest for providers that combine accessible consumer experiences with validated science, secure data governance, responsible interpretation of genetic risk, and inclusive datasets that better reflect global ancestry diversity.

As ancestry testing, health screening, pharmacogenomics, carrier testing, and wellness genomics converge, competitive advantage will shift from test volume alone to trust, evidence quality, regulatory readiness, transparency, and the ability to connect genetic insights with actionable and appropriately supported health decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Convert Preventive Health Demand Into Clinically Connected Revenue
4.3.1.2. Use WGS to Reset the Product Refresh Cycle
4.3.1.3. Scale Personalized Interpretation Through Responsible AI
4.3.1.4. Expand Adoption Through Omnichannel and B2B2C Access
4.3.2. Key Restraints
4.3.2.1. Turn Genetic Privacy From a Restraint Into a Trust Differentiator
4.3.2.2. Strengthen Clinical Utility Before Expanding Health Claims
4.3.3. Key Opportunities
4.3.3.1. Scale Sponsored Population Genomics With Measurable Care Outcomes
4.3.3.2. Monetize Reanalysis and Personal Genome Ownership
4.3.3.3. Win Underserved Populations Through Local Reference Panels
4.3.4. Key Challenges
4.3.4.1. Build Resilience Against Genomic Data and Sequencing Supply-Chain Fragmentation
4.3.4.2. Rebuild Consumer Trust After Privacy, Bankruptcy, and Interpretation Shocks
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Direct-to-Consumer Genetic Testing Market, by Test Type
7.1. Introduction
7.2. Ancestry
7.2.1. Ethnicity Estimation
7.2.2. Family Tree Building
7.2.3. Relative Matching
7.3. Health & Wellness Testing
7.3.1. Disease Risk Assessment
7.3.2. Carrier Screening
7.3.3. Pharmacogenomics
7.3.4. Nutrition & Diet Testing
7.4. Diagnostic & Preventive Testing
7.4.1. Hereditary Disease Testing
7.4.2. Cancer Risk Testing
7.4.3. Cardiovascular Risk Testing
7.5. Traits Testing
7.5.1. Physical Traits
7.5.2. Behavioral Traits
7.6. Reproductive Health Testing
7.6.1. Fertility Testing
7.6.2. Preconception Carrier Screening
8. Direct-to-Consumer Genetic Testing Market, by Technology
8.1. Introduction
8.2. Polymerase Chain Reaction (PCR)
8.3. Microarray-Based Testing
8.4. Next-Generation Sequencing (NGS)
8.4.1. Whole Genome Sequencing (WGS)
8.4.2. Whole Exome Sequencing (WES)
8.5. Single Nucleotide Polymorphism (SNP) Analysis
9. Direct-to-Consumer Genetic Testing Market, by Sample Type
9.1. Introduction
9.2. Saliva
9.3. Blood
10. Direct-to-Consumer Genetic Testing Market, by Business Model
10.1. Introduction
10.2. Direct Purchase Testing Kits
10.3. Subscription-Based Genetic Services
10.4. Data Monetization Model
10.5. Employer-Sponsored Programs
11. Direct-to-Consumer Genetic Testing Market, by End User
11.1. Introduction
11.2. Individual Consumers
11.3. Healthcare Providers
11.4. Research Organizations
11.5. Pharmaceutical & Biotechnology Companies
12. Direct-to-Consumer Genetic Testing Market, by Sales Channel
12.1. Introduction
12.2. Offline
12.3. Online
12.3.1. Company Websites
12.3.2. E-commerce Platforms
13. Direct-to-Consumer Genetic Testing Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Direct-to-Consumer Genetic Testing Market, by Group
14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC
15. Direct-to-Consumer Genetic Testing Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. France
15.8. Canada
15.9. Australia
15.10. Brazil
15.11. Italy
15.12. Mexico
15.13. South Korea
15.14. Russia
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Ancestry.com LLC
17.2. MyHeritage Ltd.
17.3. Helix OpCo LLC
17.4. DNA Diagnostics Center, Inc.
17.5. Color Health, Inc.
17.6. Living DNA Ltd.
17.7. Prenetics Global Limited
17.8. Dante Labs, Inc.
17.9. Gene by Gene, Ltd.
17.10. 24Genetics S.L.
17.11. African Ancestry, Inc.
17.12. CRI Genetics, LLC
17.13. Dynamic DNA Laboratories Inc.
17.14. EasyDNA Group
17.15. Full Genomes Corporation, Inc.
17.16. Futura Genetics Ltd.
17.17. Genesis Healthcare Co., Ltd.
17.18. Genetrack Biolabs Inc.
17.19. Genoplan Inc.
17.20. MapmyGenome India Limited
17.21. Nebula Genomics, Inc.
17.22. SelfDecode, Inc.
17.23. tellmeGen S.L.
17.24. Toolbox Genomics, Inc.
17.25. Veritas Intercontinental S.L.U.
17.26. Vitagene, Inc.
17.27. Xcode Life Sciences Private Limited
List of Figures
FIGURE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ANCESTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ANCESTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ANCESTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ETHNICITY ESTIMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ETHNICITY ESTIMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ETHNICITY ESTIMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL FAMILY TREE BUILDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL FAMILY TREE BUILDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL FAMILY TREE BUILDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL RELATIVE MATCHING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL RELATIVE MATCHING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL RELATIVE MATCHING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HEALTH & WELLNESS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HEALTH & WELLNESS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HEALTH & WELLNESS TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DISEASE RISK ASSESSMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DISEASE RISK ASSESSMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DISEASE RISK ASSESSMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CARRIER SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL NUTRITION & DIET TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL NUTRITION & DIET TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL NUTRITION & DIET TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DIAGNOSTIC & PREVENTIVE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL DIAGNOSTIC & PREVENTIVE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC & PREVENTIVE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL HEREDITARY DISEASE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL HEREDITARY DISEASE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL HEREDITARY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CANCER RISK TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CANCER RISK TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CANCER RISK TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR RISK TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR RISK TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR RISK TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TRAITS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TRAITS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TRAITS TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PHYSICAL TRAITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PHYSICAL TRAITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PHYSICAL TRAITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BEHAVIORAL TRAITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BEHAVIORAL TRAITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BEHAVIORAL TRAITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL REPRODUCTIVE HEALTH TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL REPRODUCTIVE HEALTH TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL REPRODUCTIVE HEALTH TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL FERTILITY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL FERTILITY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL FERTILITY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PRECONCEPTION CARRIER SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PRECONCEPTION CARRIER SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PRECONCEPTION CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL MICROARRAY-BASED TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MICROARRAY-BASED TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MICROARRAY-BASED TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DIRECT PURCHASE TESTING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DIRECT PURCHASE TESTING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DIRECT PURCHASE TESTING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SUBSCRIPTION-BASED GENETIC SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SUBSCRIPTION-BASED GENETIC SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SUBSCRIPTION-BASED GENETIC SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL DATA MONETIZATION MODEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL DATA MONETIZATION MODEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL DATA MONETIZATION MODEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL EMPLOYER-SPONSORED PROGRAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL EMPLOYER-SPONSORED PROGRAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL EMPLOYER-SPONSORED PROGRAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL INDIVIDUAL CONSUMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL INDIVIDUAL CONSUMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL INDIVIDUAL CONSUMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL COMPANY WEBSITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL COMPANY WEBSITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL COMPANY WEBSITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 141. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 143. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 144. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 145. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 146. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 147. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 148. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 150. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 151. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 152. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 154. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 183. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 184. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 185. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 186. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 187. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 188. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 189. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 190. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 191. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 192. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 193. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 194. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 196. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 214. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 215. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 216. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 217. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 218. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 219. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 220. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 221. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 222. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 223. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 225. NATO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 226. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 228. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 229. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 230. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 231. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 232. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 233. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 235. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 236. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 237. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 239. G7 DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 254. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 255. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 256. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 257. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 258. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 259. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 260. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 261. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 262. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 263. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 264. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 265. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 267. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 268. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 269. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 270. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 271. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 272. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 273. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 274. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 275. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 276. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 277. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 278. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 279. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 280. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 281. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 282. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 283. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 284. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 285. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 286. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 287. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 288. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 289. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 291. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 292. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 293. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 295. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 296. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BUSINESS MODEL, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SALES CHANNEL, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 311. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 313. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY, 2017-2032 (USD MILLION)
TABLE 314. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH & WELLNESS TESTING, 2017-2032 (USD MILLION)
TABLE 315. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC & PREVENTIVE TESTING, 2017-2032 (USD MILLION)
TABLE 316. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS TESTING, 2017-2032 (USD MILLION)
TABLE 317. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REPRODUCTIVE HEALTH TESTING, 2017-2032 (USD MILLION)
TABLE 318. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 319. CHINA

Companies Mentioned

  • Ancestry.com LLC
  • MyHeritage Ltd.
  • Helix OpCo LLC
  • DNA Diagnostics Center, Inc.
  • Color Health, Inc.
  • Living DNA Ltd.
  • Prenetics Global Limited
  • Dante Labs, Inc.
  • Gene by Gene, Ltd.
  • 24Genetics S.L.
  • African Ancestry, Inc.
  • CRI Genetics, LLC
  • Dynamic DNA Laboratories Inc.
  • EasyDNA Group
  • Full Genomes Corporation, Inc.
  • Futura Genetics Ltd.
  • Genesis Healthcare Co., Ltd.
  • Genetrack Biolabs Inc.
  • Genoplan Inc.
  • MapmyGenome India Limited
  • Nebula Genomics, Inc.
  • SelfDecode, Inc.
  • tellmeGen S.L.
  • Toolbox Genomics, Inc.
  • Veritas Intercontinental S.L.U.
  • Vitagene, Inc.
  • Xcode Life Sciences Private Limited

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.66 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.98 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Genetic Testing Market - Global Forecast 2026-2032 - Product Image

Genetic Testing Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Rare Disease Genetic Testing Market - Global Forecast 2026-2032 - Product Image

Rare Disease Genetic Testing Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report - Product Image

Predictive Genetic Testing and Consumer Genomics - Global Strategic Business Report

  • Report
  • 267 Pages
  • Global
From
Direct-to-Consumer (DTC) Genetic Testing - Global Strategic Business Report - Product Image

Direct-to-Consumer (DTC) Genetic Testing - Global Strategic Business Report

  • Report
  • 324 Pages
  • Global
From
Direct-to-Consumer Genetic Testing Market Size, Share & Trends Analysis Report by Test Type, Technology, Distribution Channel, Region, and Segment Forecasts, 2026-2033 - Product Image

Direct-to-Consumer Genetic Testing Market Size, Share & Trends Analysis Report by Test Type, Technology, Distribution Channel, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From

About the Direct to Consumer Genetic Testing Market

Direct to Consumer Genetic Testing (DTCGT) is a type of genetic testing that allows individuals to access their genetic information without the need for a doctor or other healthcare provider. DTCGT companies provide genetic testing services directly to consumers, typically through a simple saliva sample. The results of the test can provide insight into an individual's ancestry, health risks, and other genetic traits. The DTCGT market has grown rapidly in recent years, driven by advances in genomics technology and the increasing availability of affordable testing services. Consumers are increasingly turning to DTCGT to gain access to their genetic information and to learn more about their health and ancestry. Some of the leading companies in the DTCGT market include 23andMe, AncestryDNA, Helix, and MyHeritage. These companies offer a range of services, from ancestry testing to health risk assessments. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.